Alliances crumble in M'rashtra

September 26, 2014

New Delhi/Mumbai, Sep 26: After weeks of hardball politics, the two coalitions in Maharashtra — the ruling Congress-NCP and the opposition BJP-Shiv Sena — parted ways in a bitter way on Thursday night, setting the stage for a multi-cornered contest in the upcoming Assembly elections.

Alliances crumbleThe key players were in a wrangle over the sharing of seats for the 288-member Assembly election with the aim of dominating the political space in the state. Maharashtra goes to polls on October 15 and the last day for filing of nomination papers is Saturday.

The BJP, the junior partner in the 30-year-old alliance, was the first to announce the split with the Sena. Within an hour, the NCP walked out of the 15-year-old coalition with the Congress, plunging the state into a political flux. Buoyed by the Modi wave in the Lok Sabha elections, the BJP had been demanding 135 seats from the Shiv Sena while it had contested 119 seats in the 2009 Assembly elections.

BJP leaders have been contending that Sena’s position in the state had diminished following the death of its founder Bal Thackeray in 2012, a claim which did not find favour with its chief Uddhav Thackeray.

“The Shiv Sena-BJP alliance, which lasted over 25 years, has ended,” Maharashtra BJP leader Eknath Khadse told reporters at the party office in Mumbai.

“Even now, we and many in the Maharashtra BJP do regret that vested interests have prevailed over unity,” Aditya Thackeray, the 24-year-old son of Uddhav, posted on Twitter.

The Shiv Sena is the second ally after the Haryana Janhit Congress to part ways with the BJP after its spectacular success in the Lok Sabha elections. However, Sena’s lone representative in the Union Cabinet Anant Geete said the alliance would continue at the Centre.

On the other hand, the NCP was demanding an equal share from the Congress. The NCP, which won four seats in the recent Lok Sabha elections, argued that the influence of the Congress is limited as the party managed to secure only two seats.

Announcing the NCP-Congress split, Deputy Chief Minister Ajit Pawar accused Chief Minister Prithviraj Chavan of ignoring the alliance partner of 15 years and creating an atmosphere of distrust.

Pawar also announced that the NCP was withdrawing support to the state government and he will meet Governor Ch Vidyasagar Rao to submit his resignation.

“Unbelievable and unimaginable has happened. Ekla chalo won; all four parties lose at least something. But politically best way to grow strong,” Congress spokesman Abhishek Manu Singhvi said.

Earlier, the first signs of an impending separation in the saffron alliance came as BJP president Amit Shah cancelled his visit to Mumbai on Thursday even as last minute efforts were on to save the coalition.

The seat sharing talks between the Sena and the BJP witnessed several twists and turns.

The alliance was finalised two days back only to be rocked by minor partners who were not willing to accept the “raw deal” offered to them.

The Sena had kept 151 seats for itself, offering 130 to the BJP while leaving seven seats to the four minor parties — Swabhimani Paksha, RPI (A), Rashtriya Samaj Paksha and Shiv Sangram.

According to an earlier proposal, the Sena had 151 seats, BJP 119 while the four minor parties had 18. Another bone of contention between the BJP and the Shiv Sena was the post of the chief minister.

Sena had staked claim to the post citing the agreement between Bal Thackeray and BJP leader Pramod Mahajan, who had first struck the alliance in the 1980’s. BJP was keen to have the post contending that it had been performing better than the Sena in the state elections.

In the current Assembly, the BJP has 46 members as against 45 of the Sena. The superior performance of the BJP in the 2009 elections had resulted in the nomination of its leader Eknath Khadse as the Leader of the Opposition in the Assembly.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 5,2020

Mar 5: The fourteen Italians, who have tested positive for coronavirus, have been shifted to the Medanta Hospital in Gurgaon from an ITBP quarantine centre.

The hospital issued a statement on Thursday morning, saying these patients are housed on a completely separate floor, which has been quarantined and has no contact with the rest of the hospital.

There is a dedicated medical team wearing protective gear looking after these patients.All items used on the floor are isolated to that floor.

The isolated floor will completely contain the disease even with these asymptomatic persons. All other hospital operations are operating as normal, and there is no increased risk to patients, visitors or staff, the statement said.

Twenty-one Italian tourists and their three Indian tour operators were shifted out from an ITBP quarantine centre here on Wednesday as they were exposed to novel coronavirus.

An affected Italian couple is being treated at Jaipur's SMS medical college.

Officials on Tuesday said the foreigners have been sent to a private hospital in Gurgaon and a centre in the national capital while the Indians have been transferred to the Safdarjung Hospital.

Fourteen Italians and an Indian (driver), who were in the same group as the affected Italian couple, tested positive for the virus as per information provided by the Health Ministry.

The Italian tourists and three Indians were admitted to the Indo-Tibetan Border Police (ITBP) force centre in Chhawla on Tuesday.

The Centre already has 112 people, 76 Indians and 36 foreigners, since February 27 after they were evacuated by an Indian Air Force (IAF) plane from China's Wuhan, the epicentre of the deadly coronavirus.

The first samples of these 112 people had tested negative when reports came in last week.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 17,2020

Tehran, May 17: As many as 310 Indian pilgrims departed from Tehran, Iran for New Delhi by Mahan Air on Saturday. The group hails from Ladakh and will later go home to Leh by special flights.

"A group of 310 Indian pilgrims, hailing from Ladakh, departed Tehran for New Delhi by Mahan Air tonight (16th May). 
Thereafter, they'll go home to Leh by special flights," Embassy of India in Iran wrote on Twitter.

On Saturday, Minister of Civil Aviation, Hardeep Singh Puri said that over 13,000 people have returned under the Vande Bharat repatriation mission till date.

"More than 13,000 people have already returned on various flights under Mission Vande Bharat so far. Today, 812 citizens have returned on Air India and AirIndia Express flights from Newark, London, Dubai and Abu Dhabi. More flights continue," Puri wrote on Twitter.

Vande Bharat Mission, which started on May 7 to bring back stranded Indian nationals back home from other countries, initiated its second phase of the operation from Saturday (May 16) by sending three Air India flights to Dubai and Abu Dhabi.

Under the second phase of Vande Bharat Mission a total of 149 flights, including feeder flights, will be operated to bring back Indians from 40 countries. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.